Zobrazeno 1 - 10
of 45
pro vyhledávání: '"Elizabeth F Krakow"'
Publikováno v:
Frontiers in Immunology, Vol 14 (2023)
BackgroundPre-clinical development and in-human trials of ‘off-the-shelf’ immune effector cell therapy (IECT) are burgeoning. IECT offers many potential advantages over autologous products. The relevant HLA matching criteria vary from product to
Externí odkaz:
https://doaj.org/article/7e49a1f35754430a8c49d3c705a4013f
Autor:
Huisheng Ai, Nelson J. Chao, David A. Rizzieri, Xiaojun Huang, Thomas R. Spitzer, Jianxiang Wang, Mei Guo, Armand Keating, Elizabeth F. Krakow, Didier Blaise, Jun Ma, Depei Wu, John Reagan, Usama Gergis, Rafael F. Duarte, Preet M. Chaudhary, Kaixun Hu, Changlin Yu, Qiyun Sun, Ephraim Fuchs, Bo Cai, Yajing Huang, Jianhui Qiao, David Gottlieb, Kirk R. Schultz, Mingyao Liu, Xiequn Chen, Wenming Chen, Jianmin Wang, Xiaohui Zhang, Jianyong Li, He Huang, Zimin Sun, Fei Li, Linhua Yang, Liansheng Zhang, Lijuan Li, Kaiyan Liu, Jie Jin, Qifa Liu, Daihong Liu, Chunji Gao, Chuanbo Fan, Li Wei, Xi Zhang, Liangding Hu, Weijing Zhang, Yuyang Tian, Weidong Han, Jun Zhu, Zhijian Xiao, Daobin Zhou, Bolong Zhang, Yongqian Jia, Yongqing Zhang, Xiaoxiong Wu, Xuliang Shen, Xuzhang Lu, Xinrong Zhan, Xiuli Sun, Yi Xiao, Jingbo Wang, Xiaodong Shi, Bo Zheng, Jieping Chen, Banghe Ding, Zhao Wang, Fan Zhou, Mei Zhang, Yizhuo Zhang, Jie Sun, Bing Xia, Baoan Chen, Liangming Ma
Publikováno v:
Heliyon, Vol 9, Iss 4, Pp e14924- (2023)
Recent studies have shown that microtransplant (MST) could improve outcome of patients with elderly acute myeloid leukemia (EAML). To further standardize the MST therapy and improve outcomes in EAML patients, based on analysis of the literature on MS
Externí odkaz:
https://doaj.org/article/856fec91f1344a8b9074383ae4ab2604
Autor:
Natalie L. Wu, Amanda I. Phipps, Kevin R. Krull, Karen L. Syrjala, Paul A. Carpenter, Laura S. Connelly-Smith, Mary E. Flowers, Elizabeth F. Krakow, Masumi Ueda Oshima, Stephanie J. Lee, Eric J. Chow
Publikováno v:
Blood Advances. 6:4347-4356
Survivors of hematopoietic cell transplant (HCT) are at risk for neurocognitive impairments, which can negatively affect quality of life. Given limited studies, we aimed to describe the neurocognitive outcomes in a cohort of long-term adult HCT survi
Autor:
Julia M. Nathe, Elizabeth F. Krakow
Publikováno v:
MDM Policy & Practice, Vol 4 (2019)
Importance. Oncology trials often entail high-stakes interventions where potential for morbidity and fatal side effects, and for life-prolongation or cure, intensify bioethical issues surrounding informed consent. These challenges are compounded in m
Externí odkaz:
https://doaj.org/article/221c947a2ec94100ad0ddb6281445875
Autor:
Nicolas Savy, Erica EM Moodie, Isabelle Drouet, Antoine Chambaz, Bruno Falissard, Michael R. Kosorok, Elizabeth F. Krakow, Deborah G. Mayo, Stephen Senn, Mark Van der Laan
Publikováno v:
International Journal of Biostatistics
SMAC 2021 was a webconference organized in June 2021. The aim of this conference was to bring together data scientists, (bio)statisticians, philosophers, and any person interested in the questions of causality and Bayesian statistics, ranging from te
Autor:
Elizabeth F, Krakow
Publikováno v:
The International Journal of Biostatistics.
Autor:
Paul A. Carpenter, Ted A. Gooley, Julie R Boiko, Nahid Rashid, Albert Yeh, Phuong Vo, Masumi Ueda Oshima, Rachel B. Salit, Elizabeth F. Krakow, Mary E.D. Flowers, Lauri M. Burroughs, Neel S. Bhatt, Corinne Summers, Stephanie J Lee
Publikováno v:
Transplantation and Cellular Therapy. 29:S254-S255
Autor:
Emily Geramita, Kedwin Ventura, Shruti Bhise, Erika Moore, Elizabeth F. Krakow, Geoffrey R Hill, Scott N Furlan, Warren D Shlomchik, Sawa Ito
Publikováno v:
Transplantation and Cellular Therapy. 29:S45-S46
Autor:
Elizabeth F. Krakow, Ryan C. Lynch, Sandra Kanan, Karolyn Morris, Lorinda Soma, Stephen D. Smith, Ryan D. Cassaday, Thomas R. Chauncey, Solomon A. Graf, Sanaz Behnia, Jenna M. Voutsinas, Heather Rasmussen, Qian Vicky Wu, Ajay K. Gopal
Publikováno v:
Clin Lymphoma Myeloma Leuk
Background Histologic transformation to diffuse large B-cell lymphoma (tDLBCL) occurs in a significant proportion of indolent lymphomas. However, few studies of novel agents inform its management, particularly when relapsed after or refractory (R/R)
Autor:
Nahid Rashid, Albert Yeh, Marco Mielcarek, Masumi Ueda Oshima, Elizabeth F Krakow, Lynn E. Onstad, Laura Connelly-Smith, Phuong Vo, Stephanie J. Lee
Publikováno v:
Blood. 140:10552-10553